Who is sponsoring NCT04162912?

NCT04162912 is sponsored by Food and Health Bureau, Hong Kong.

What condition does NCT04162912 study?

NCT04162912 studies End Stage Disease.

Is NCT04162912 still recruiting?

NCT04162912 is currently completed. Last updated 17 April 2020.

Last reviewed 2020-04-17 · How we verify

NCT04162912

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Motivational Interviewing Tailored Programme for Promoting Advance Care Planning Behaviours

Completed NA Last updated 17 April 2020

What this trial tests

NA trial testing Motivational Interviewing tailored Advance Care Planning in End Stage Disease in 204 participants. Completed in 31 December 2019.

Timeline

1 January 2018

Primary endpoint
31 December 2019

31 December 2019

Quick facts

Lead sponsor	Food and Health Bureau, Hong Kong
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	204
Start date	1 January 2018
Primary completion	31 December 2019
Estimated completion	31 December 2019
Sites	2 locations across Hong Kong

Drugs / interventions tested

Motivational Interviewing tailored Advance Care Planning

Conditions studied

End Stage Disease — all drugs for End Stage Disease →

Sponsor

Food and Health Bureau, Hong Kong

Who can join

18 and older, any sex, with End Stage Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This proposed study is designed to test the effects of motivational interviewing (MI) in increasing the uptake of ACP behaviours among patients with palliative care needs. A randomised controlled trial with repeated blinded outcome assessment will be conducted to assess the effects of a MI-tailored ACP (MI-ACP) programme on palliative care patients recruited from the outpatient palliative care clinics and home palliative care services of two hospitals. A total of 204 patients will be recruited and randomly assigned to experimental and control groups. The patients in the experimental group will receive a MI-ACP programme facilitated by a trained nurse, whereas the patients in the control group will receive usual care. Primary outcome is the behavioural changes in ACP. Secondary outcomes are perceived stress, decisional conflict and quality of life. Study outcomes will be measured at baseline, 1 month and 3 months after enrolment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of motivational interviewing to promote advance care planning among palliative care patients in ambulatory care setting: a randomized controlled trial.
Chan HY, Leung DY, Lam PT, Ko PP, et al · · 2025 · cited 1× · PMID 39891169 · DOI 10.1186/s12904-025-01667-9

Verify or expand the search:

Other recruiting trials for End Stage Disease

Currently open trials in the same condition.

NCT04778761 — ACP Video Intervention for Patients With Life-Limiting Illness · NA · recruiting

Other Food and Health Bureau, Hong Kong trials

Trials by the same sponsor.

NCT06008210 — A Decision Aid on End-of-life Care for Patients With Advanced COPD and Their Family · NA · completed
NCT05422729 — mHealth-supported Coach · NA · unknown
NCT04352387 — Montessori Based Activities for Dementia · NA · completed
NCT03599310 — Effects of a Structured Advance Care Planning Guide Among Patients With Advanced Illness in Hospital Care Settings · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04162912 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Food and Health Bureau, Hong Kong
Last refreshed: 17 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04162912.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing